About Us

SINOPEG is dedicated to drug delivery systems and related medical device business, focusing on the research, development, production and sales of high-end drug delivery carriers/auxiliary materials/APIs, medical materials, including but not limited to polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, viral-like particles, as well as providing CDMO and solution services. These products are widely used in long-acting protein/peptide drugs, COVID-19 mRNA vaccines, small nucleic acid drugs, blood sugar control drugs, macromolecular micelle drugs, liposome drugs, gene therapy drugs, immunosuppressants, ADC drugs, ProTAC drugs, medical hydrogels, and other fields, placing the company in a leading position in the industry.

SINOPEG has a technical team led by overseas returned doctors and foreign experts, established good cooperation relations with well-known universities and research institutes in China, such as Xiamen University, Fudan University and the Institute of Chemistry of Chinese Academy of Sciences. The company has the first-class technology development strength, provides services including the reaction, purification, separation and end product analysis and others according to customer needs.

With proprietary technologies and state-of-the-art GMP standard manufacturing capability, SINOPEG is capable of supplying small to large quantities of rich selection of PEG derivative products with unique molecular designs (chemical structure, molecular weights (MW)) and exceptional product quality control to serve bio-technology and pharmaceutical companies and research organizations worldwide.

SINOPEG is proud collaborator with a number of well-known universities, research institutes, and pharmaceutical and biotech companies around the globe.

Our Vision

SINOPEG’s vision is to be an science company, providing innovative materials and technology to partner with our customers on current treatment improvement and new therapeutics development for improved patient treatment quality and better human health.

Our Mission

SINOPEG partners with our customers and collaborators to create value through:

  •  Provide innovative products to enable technology advancement and differentiation.
  •  Extend services to accelerate novel treatment development and evaluation (conjugation chemistry,product separation and characterization, drug candidate evaluation).

  • Focus on efficiency and result to maximize return of customer’s investments.

Our Advantage

  • SINOPEG holds 30 IP, 25 pending IP.
  • ISO-9001and ISO-13485 certified.
  • 16 DMFs that meet FDA requirements.

Certificate Of Analysis (COA)

COAs will be provided for all products ordered from SINOPEG.

Special Customization

SINOPEG is able to customize a wide range of drug delivery system accessory products from mg to kg, and our products can meet the specific requirements of customers. 

Copyright © XIAMEN SINOPEG BIOTECH CO., LTD. All Rights Reserved.